Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood

NCT04285814 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04285814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04285814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
September 1, 2020
Completion date
July 20, 2023
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copy number abnormality, genetic disease, prenatal diagnosis